US Patent Issued to Reprieve Cardiovascular on March 25 for "Fluid therapy based on sodium excretion, and associated systems, devices, and methods" (California, Connecticut, Massachusetts Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,416, issued on March 25, was assigned to Reprieve Cardiovascular Inc. (Milford, Mass.).

"Fluid therapy based on sodium excretion, and associated systems, devices, and methods" was invented by Andrew V. Halpert (Brookline, Mass.), Antony Jonathan Fields (San Francisco) and Jeffrey Testani (New Haven, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This present disclosure relates to fluid therapy based on sodium excretion, and associated systems, devices, and methods. Exemplary methods can include receiving a sodium excretion input for the patient; receiving a urine output rate; determining an adjusted urine output rate based on the sodium excre...